Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Centralized post-marketing safety monitoring study of leonurus japonicus injection
ChiCTR-OPN-15006712Phase 4Completed
- Sponsor
- West China Second University Hospital
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of yimucao in postpartum hemorrhage (PPH) and Irregular Menstruation, sponsored by West China Second University Hospital. Primary endpoints: Untoward effect and Adverse reaction rate. Started Jul 2015; status: completed.
02
Drugs
yimucao
03
Conditions
postpartum hemorrhage (PPH)Irregular Menstruation
Beyond the preview
Go deeper on ChiCTR-OPN-15006712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-15006712.